Chronisch-immunvermittelte Neuropathien – Diagnostik und Therapie

Alexander Grimm; Hubertus Axer

doi:10.1055/a-0840-1606

Neuroradiologie Scan, Table of Contents

Neuroradiologie Scan 2019; 09(02): 147-162
DOI: 10.1055/a-0840-1606

CME-Fortbildung

Chronisch-immunvermittelte Neuropathien – Diagnostik und Therapie

Authors

Alexander Grimm
Hubertus Axer

Subject Editor: Wissenschaftlich verantwortlich gemäß Zertifizierungsbestimmungen für diesen Beitrag ist PD Dr. med. Alexander Grimm, Tübingen

Abstract

Die Diagnose einer immunvermittelten Neuropathie ist eine der wichtigsten Diﬀerenzialdiagnosen bei Polyneuropathien. Chronisch-inﬂammatorische Neuropathien haben oft eine schwere neurologische Beeinträchtigung zur Folge. Deswegen ist eine frühzeitige Diagnose zur Einleitung einer antientzündlichen Therapie essenziell. Therapiekonzepte beinhalten je nach Pathologie Immunglobuline, Kortikosteroide oder Plasmaaustauschverfahren.

Schlüsselwörter

Chronisch-immunvermittelte Polyneuropathien - Diagnostik - Therapie

Full Text

References

Literatur
1 Latov N. Diagnosis and treatment of chronic acquired demyelinating polyneuropathies. Nat Rev Neurol 2014; 10: 435-446
2 Dalakas MC. Advances in the diagnosis, pathogenesis and treatment of CIDP. Nat Rev Neurol 2011; 7: 507-517
3 Lewis RA. Chronic inﬂammatory demyelinating polyneuropathy. Curr Opin Neurol 2017; 30: 508-512
4 Sinnreich M, Klein CJ, Daube JR. et al. Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia. Neurology 2004; 63: 1662-1669
5 EFNS-PNS Task Force. European Federation of Neurological Societies/Peripheral Nerve Society Guideline on management of chronic inﬂammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society – First Revision. Eur J Neurol 2010; 17: 356-363
6 Gasparotti R, Padua L, Briani C. et al. New technologies for the assessment of neuropathies. Nat Rev Neurol 2017; 13: 203-216
7 Grimm A, Vittore D, Schubert V. et al. Ultrasound aspects in therapy-I CIDP compared to long-term treated CIDP. J Neurol 2016; 263: 1074-1082
8 Querol L, Devaux J, Rojas-Garcia R. et al. Autoantibodies in chronic inﬂammatory neuropathies: diagnostic and therapeutic implications. Nat Rev Neurol 2017; 13: 533-547
9 Mathey EK, Garg N, Park SB. et al. Autoantibody responses to nodal and paranodal antigens in chronic inﬂammatory neuropathies. J Neuroimmunol 2017; 309: 41-46
10 Mauermann ML. Paraproteinemic neuropathies. Continuum (Minneap Minn) 2014; 20: 1307-1322
11 Steck AJ, Stalder AK, Renaud S. Anti-myelin-associated glycoprotein neuropathy. Curr Opin Neurol 2006; 19: 458-463
12 Rattay TW, Winter N, Décard B. et al. Nerve ultrasound as follow-up tool in treated multifocal motor neuropathy. Eur J Neurol 2017; 24: 1125-1134
13 Nobile-Orazio E, Gallia F. Multifocal motor neuropathy: current therapies and novel strategies. Drugs 2013; 73: 397-406
14 Diener H-C. Leitlinien für Diagnostik und Therapie in der Neurologie. 5. Auﬂ. Stuttgart: Thieme; 2012
15 Gwathmey KG, Burns TM, Collins MP. et al. Vasculitic neuropathies. Lancet Neurol 2014; 13: 67-82
16 Burns TM, Schaublin GA, Dyck PJB. Vasculitic neuropathies. Neurol Clin 2007; 25: 89-113
17 Blaes F. Diagnosis and therapeutic options for peripheral vasculitic neuropathy. Ther Adv Musculoskelet Dis 2015; 7: 45-55
18 Collins MP, Hadden RD. The nonsystemic vasculitic neuropathies. Nat Rev Neurol 2017; 13: 302-316
19 Grimm A, Décard BF, Bischof A. et al. Ultrasound of the peripheral nerves in systemic vasculitic neuropathies. J Neurol Sci 2014; 347: 44-44
20 Collins MP, Dyck PJB, Gronseth GS. et al. Peripheral Nerve Society: Peripheral Nerve Society Guideline on the classiﬁcation, diagnosis, investigation, and immunosuppressive therapy of non-systemic vasculitic neuropathy: executive summary. J Peripher Nerv Syst 2010; 15: 176-184